Fuchs

tfuchs
pfeil nach oben

This research project will analyse the population heterogeneity of Salmonella enterica serovar Typhimurium (S. Typhimurium) during growth with myo-inositol (MI) as sole carbon and energy source. Hallmarks of S. Typhimurium growth with MI are two distinct phenotypes, an extended lag phase of two days, the manifestation of hysteresis, stochastic bistability of at least one iol promoter, positive and negative feedback-loops involving the novel inducer ReiD and the repressor IolR, and the influence of external stimuli. Since MI-utilization contributes to Salmonella virulence, this is a unique example of a stochastically switching metabolic property linked with bacterial pathogenicity.


References:

  • List of publications (T. Fuchs)

Contact details:


Prof. Dr. Thilo Fuchs
ZIEL, Abteilung Mikrobiologie
Technische Universität München
Weihenstephaner Berg 3
Raum O/3.01.1
D-85354 Freising
Tel.: +49-(0)8161-713518
Fax.: +49-(0)8161-714492
thilo.fuchs(at)wzw.tum.de
Homepage Link


Co-workers: N.N. (Ph. D. student funded by SPP1617), Jessica Hellinckx (student), Johannes Rothhardt (related project)

 


References:


Fuchs


Rothhardt, J. E., Kröger, C., Broadley, S. P. and Fuchs, T. M. (2014) The orphan regulator ReiD of Salmonella enterica is essential for myo-inositol utilization. Mol. Microbiol., 94, 700-712.

Kröger, C., Srikumar, S., Ellwart, J. and Fuchs, T. M. (2011) Bistability in myo-inositol utilization by Salmonella enterica serovar Typhimurium. J. Bacteriol., 193, 1427-1435.

Kröger, C., Stolz, J. and Fuchs, T. M. (2010) myo-Inositol transport by Salmonella enterica serovar Typhimurium. Microbiology (Reading, Engl.), 156, 128-138.

Kröger, C. and Fuchs, T. M. (2009) Characterization of the myo-inositol utilization island of Salmonella enterica serovar Typhimurium. J. Bacteriol., 191, 545-554.

Heermann, R. and Fuchs, T. M. (2008) Comparative analysis of the Photorhabdus luminescens and the Yersinia enterocolitica genomes: uncovering candidate genes involved in insect pathogenicity. BMC Genomics, 9, 40.